These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2510749)

  • 1. [The erythrocyte phenotype Rh: 32,-46: transfusional and obstetric importance].
    Le Pennec PY; Rouger P; Klein MT; Salmon C
    Rev Fr Transfus Hemobiol; 1989 Sep; 32(4):291-7. PubMed ID: 2510749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serologic study of red cells and sera from 18 Rh:32,-46 (RN/RN) persons.
    Le Pennec PY; Rouger P; Klein MT; Kornprobst M; Brossard Y; Boizard B; Salmon C
    Transfusion; 1989; 29(9):798-802. PubMed ID: 2511647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic disease of the newborn caused by anti-Rh32 and demonstration that RN encodes rhi (Ce,Rh7).
    Issitt PD; Gutgsell NS; Martin PA; Forguson JR
    Transfusion; 1991 Jan; 31(1):63-6. PubMed ID: 1898787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specificity of antibodies formed in people with Rh-negative blood in response to administration to antigens C(rh', Rh2) and Cw(rhwf, Rh8)].
    Morokov VA
    Gematol Transfuziol; 1995; 40(5):15-7. PubMed ID: 8566653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh(D) alloimmunization in the absence of exposure to Rh(D) antigen.
    Biggins KR; Bowman JM
    Vox Sang; 1986; 51(3):228-30. PubMed ID: 3101288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frozen recovered red cell boosting of female donors for anti-D-production.
    Gabra GS; Black M; Mitchell R
    Vox Sang; 1986; 50(3):137-40. PubMed ID: 3087060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
    Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
    Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rh immunization by the partial D antigen of category DVa.
    Mayne K; Bowell P; Woodward T; Sibley C; Lomas C; Tippett P
    Br J Haematol; 1990 Dec; 76(4):537-9. PubMed ID: 2124920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunized pregnant woman with rare Rh fenotype--case report].
    Budakov Z; Milosavljević Knezević N; Grujić J; Krga Milanović M
    Med Pregl; 2013; 66(1-2):81-5. PubMed ID: 23534305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FPTT is a low-incidence Rh antigen associated with a "new" partial Rh D phenotype, DFR.
    Lomas C; Grässmann W; Ford D; Watt J; Gooch A; Jones J; Beolet M; Stern D; Wallace M; Tippett P
    Transfusion; 1994 Jul; 34(7):612-6. PubMed ID: 7519797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D category IV: a group of clinically relevant and phylogenetically diverse partial D.
    von Zabern I; Wagner FF; Moulds JM; Moulds JJ; Flegel WA
    Transfusion; 2013 Nov; 53(11 Suppl 2):2960-73. PubMed ID: 23461862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization to multiple rh antigens by transfusion of random donor platelet concentrates in a -D- phenotype patient.
    Yun JW; Kang ES; Ki CS; Koh KC; Kim DW
    Ann Lab Med; 2012 Nov; 32(6):429-32. PubMed ID: 23130343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 17. Two examples of an inseparable antibody that reacts equally well with DW+ and Rh32+ red blood cells.
    Reid ME; Sausais L; Zaroulis CG; Mohandas K; Coghlan G; Lomas-Francis C
    Vox Sang; 1998; 75(3):230-3. PubMed ID: 9852412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
    Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rh, Du phenotype in the pregnant woman].
    Lipitz S; Alcalay M
    Harefuah; 1990 Apr; 118(7):386-7. PubMed ID: 2112505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.